Location: United States
Total raised: $23M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.11.2025 | Series B | $23M | Intuitive ... |
Mentions in press and media 4
| Date | Title | Description |
| 19.11.2025 | VahatiCor: $23 Million Series B Raised To Advance A-FLUX Development For Coronary Microvascular Dysfunction | VahatiCor announced that it has closed a $23 million Series B financing round to accelerate the clinical and engineering development of its A-FLUX Reducer System, a device intended to improve myocardial perfusion for patients suffering from... |
| 18.11.2025 | VahatiCor Raises $23M in Series B Funding | VahatiCor, a Santa Clara, CA-based medtech company which specializes in cardiac care for coronary microvascular dysfunction (CMD), raised $23M in Series B funding. The round was led by S3 Ventures, with participation from Intuitive Ventures... |
| 18.11.2025 | VahatiCor Secures $23M to Combat Coronary Microvascular Dysfunction (CMD) | What You Should Know: – VahatiCor, a medtech company focused on transforming cardiac care secures $23M in Series B funding led by S3 Ventures, with support from Intuitive Ventures and a strategic investor. – The capital infusion will be use... |
| - | VahatiCor | “Vahaticor - Vahaticor” |